Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients

Santiago, Rayra Pereira; Guarda, Caroline Conceição; Figueiredo, Camylla Vilas Boas; Fiuza, Luciana Magalhaes; Aleluia, Milena Magalhães; Adanho, Corynne Stephanie Ahouefa; Carvalho, Magda Oliveira Seixas; Pitanga, Thassila Nogueira; Zanette, Dalila Lucíola; Lyra, Isa Menezes; Nascimento, Valma Maria Lopes; Vercellotti, Gregory M; Belcher, John D; Goncalves, Marilda de Souza.
Artículo en Inglés | ARCA | ID: arc-29089

Documentos relacionados

  1. Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer
  2. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
  3. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
  4. Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease.
  5. Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
  6. Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.
  7. Collegiate management in inpatient pediatric unit from health professionals’ perspective
  8. Haptoglobin or Hemopexin Therapy Prevents Acute Adverse Effects of Resuscitation After Prolonged Storage of Red Cells.
  9. Association between haptoglobin, hemopexin and mortality in adults with sepsis.
  10. Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions.